Literature DB >> 16415074

Regulation of antisense RNA expression during cardiac MHC gene switching in response to pressure overload.

F Haddad1, A X Qin, P W Bodell, L Y Zhang, H Guo, J M Giger, K M Baldwin.   

Abstract

Hypertension has been shown to cause cardiac hypertrophy and a shift in myosin heavy chain (MHC) gene expression from the faster alpha- to slower beta-MHC isoform. The expression of the beta- and alpha-MHC pre-mRNAs, mRNAs, as well as the newly discovered antisense beta-RNA were analyzed in three regions of the normal control (NC) and 12-day pressure-overloaded (AbCon) hearts: the left ventricle apex, left ventricle base, and the septum. The RNA analyses in the AbCon heart targeted both the 5' and the 3' ends of each RNA molecule. beta-MHC mRNA expression significantly increased relative to control in all three regions, regardless of the target site (5' or 3' end). In contrast, beta-MHC pre-mRNA expression in the AbCon heart depended on the site of the measurement (5' vs. 3' end). For example, whereas the pre-mRNA did not change when targeted at the 3' end (last intron), it increased significantly in the AbCon heart when measurement targeted the 5' end (2nd intron) of the 25-kb molecule. Analyses of the antisense beta-RNA revealed that its expression in the AbCon heart was significantly decreased relative to control regardless of its measurement site. A negative correlation was observed between the beta-mRNA expression and the antisense beta-RNA (P < 0.05), suggesting an inhibitory role of antisense RNA on the sense beta-MHC gene expression. In contrast, a positive correlation was observed between the antisense beta-RNA and the alpha-MHC pre-mRNA (P < 0.05). This latter observation along with the alpha-MHC gene position relative to that of the beta-antisense suggest that the alpha-MHC sense and beta-antisense transcription are coregulated likely via common intergenic regulatory sequences. Our results suggest that the increased beta-MHC expression in the AbCon heart not only is the result of increased beta-MHC transcription but also involves an antisense beta-RNA regulation scheme. Although the exact mechanism concerning antisense regulation is not clear, it could involve modulation of both transcriptional activity of the beta-MHC gene and posttranscriptional processing.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16415074     DOI: 10.1152/ajpheart.01111.2005

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  23 in total

Review 1.  Interplay of chromatin modifications and non-coding RNAs in the heart.

Authors:  Prabhu Mathiyalagan; Samuel T Keating; Xiao-Jun Du; Assam El-Osta
Journal:  Epigenetics       Date:  2013-10-10       Impact factor: 4.528

2.  Intergenic bidirectional promoter and cooperative regulation of the IIx and IIb MHC genes in fast skeletal muscle.

Authors:  Chiara Rinaldi; Fadia Haddad; Paul W Bodell; Anqi X Qin; Weihua Jiang; Kenneth M Baldwin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-04-23       Impact factor: 3.619

3.  Direct RNA sequencing.

Authors:  Fatih Ozsolak; Adam R Platt; Dan R Jones; Jeffrey G Reifenberger; Lauryn E Sass; Peter McInerney; John F Thompson; Jayson Bowers; Mirna Jarosz; Patrice M Milos
Journal:  Nature       Date:  2009-09-23       Impact factor: 49.962

4.  Regulation of myosin heavy chain antisense long noncoding RNA in human vastus lateralis in response to exercise training.

Authors:  Clay E Pandorf; Fadia Haddad; Tomasz Owerkowicz; Leslie P Carroll; Kenneth M Baldwin; Gregory R Adams
Journal:  Am J Physiol Cell Physiol       Date:  2020-03-04       Impact factor: 4.249

5.  Regulation of an antisense RNA with the transition of neonatal to IIb myosin heavy chain during postnatal development and hypothyroidism in rat skeletal muscle.

Authors:  Clay E Pandorf; Weihua Jiang; Anqi X Qin; Paul W Bodell; Kenneth M Baldwin; Fadia Haddad
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-01-18       Impact factor: 3.619

6.  miR-155 functions downstream of angiotensin II receptor subtype 1 and calcineurin to regulate cardiac hypertrophy.

Authors:  Yong Yang; Yong Zhou; Zheng Cao; Xin Zhu Tong; Hua Qiang Xie; Tao Luo; Xian Ping Hua; Han Qin Wang
Journal:  Exp Ther Med       Date:  2016-07-05       Impact factor: 2.447

7.  Development of dilated cardiomyopathy in Bmal1-deficient mice.

Authors:  Mellani Lefta; Kenneth S Campbell; Han-Zhong Feng; Jian-Ping Jin; Karyn A Esser
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-06-15       Impact factor: 4.733

8.  HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.

Authors:  Jenny Y Y Ooi; Natasha K Tuano; Haloom Rafehi; Xiao-Ming Gao; Mark Ziemann; Xiao-Jun Du; Assam El-Osta
Journal:  Epigenetics       Date:  2015-05-05       Impact factor: 4.528

9.  Increase in cardiac myosin heavy-chain (MyHC) alpha protein isoform in hibernating ground squirrels, with echocardiographic visualization of ventricular wall hypertrophy and prolonged contraction.

Authors:  O Lynne Nelson; Bryan C Rourke
Journal:  J Exp Biol       Date:  2013-09-26       Impact factor: 3.312

Review 10.  Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure.

Authors:  Mahesh P Gupta
Journal:  J Mol Cell Cardiol       Date:  2007-07-21       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.